Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $97.6, a high estimate of $103.00, and a low estimate of $93.00. This upward trend ...

Truist analyst Richard Newitter lowered the firm’s price target on Globus Medical (GMED) to $82 from $90 and keeps a Hold rating on the shares.

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Globus Medical (GMED – Research Report). The ...

MedPage Today celebrated its 20th anniversary on March 15. To get a sense of its early days -- and the new ground it was ...

Globus Medical, Inc. reported $657,293 million in sales and $60,275 million in operating profit for the quarter ending December 31, 2024, which was above both Wall Street’s expectations and management ...

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are going to take a look at where Globus Medical, Inc. (NYSE:GMED ...

Here are three updates to know on medtech company Globus Medical, as reported on by Becker’s since Feb. 6: 1. Globus Medical is inching closer to FDA clearance for its XR augmented reality headset. It ...

They’ll need their sundae best. The founders of ice cream brand Ben & Jerry’s are exploring buying back their company from Unilever Plc — as the namesakes claim the corporation interferes ...

The chart above depicts the trend in analyst earnings per share (EPS) forecasts for Globus Medical for the upcoming quarter. Analysts have increased this quarter's expectations by 3.6% for EPS ...

Airglove Medical founder Gio Benedetti said: “Airglove represents a breakthrough in what is a very traditional approach to cannulating patients which, whilst it works for many, can also cause ...